Isabel Verduyn van Weegen

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Isabel Verduyn van Weegen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evommune, Inc. Director, 10%+ Owner Common Stock 5,288,313 $147,438,166 $27.88 17 Feb 2026 By LSP 7 Cooperatief U.A.
Evommune, Inc. Director, 10%+ Owner Series A Preferred Stock 0 07 Nov 2025 By LSP 7 Cooperatief U.A.
Evommune, Inc. Director, 10%+ Owner Series B Preferred Stock 0 07 Nov 2025 By LSP 7 Cooperatief U.A.
Evommune, Inc. Director, 10%+ Owner Series C Preferred Stock 0 07 Nov 2025 By LSP 7 Cooperatief U.A.

Insider Reports Filed by Isabel Verduyn van Weegen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EVMN Evommune, Inc. 17 Feb 2026 1 +$9,999,998 4 Director, 10%+ Owner 18 Feb 2026, 21:19
/report/000209494125000004-verduyn-van-weegen-felice-isabel-2025-11-07 Evommune, Inc. 07 Nov 2025 5 +$25,000,000 4 Director, 10%+ Owner 12 Nov 2025, 16:24
/report/000209494125000002-verduyn-van-weegen-felice-isabel-2025-11-05 Evommune, Inc. 05 Nov 2025 0 $0 3 Director, 10%+ Owner 05 Nov 2025, 20:11